INDIA GLYCOLS LTD
INDIAGLYCO · General/Diversified · NSE
₹963
Current Market Price
Fair Value (DCF)
₹459
Margin of Safety
-52.3%
Updated just now
YieldIQ Score
48/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
8%
ROE
—
Debt/Equity
0.86
WACC
11.1%
Market Cap
₹6,456 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
11.2%
Return on capital employed
EV / EBITDA
12.5×
Enterprise multiple
Debt / EBITDA
3.0×
Leverage vs earnings
Interest Coverage
3.1×
EBIT covers interest
Current Ratio
0.78×
Short-term liquidity
Asset Turnover
0.61×
Revenue per ₹ of assets
Revenue CAGR (3Y)
10.2%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹963.25
Bear case
₹410.24
MoS -134.8%
Base case
₹459.47
MoS -109.6%
Bull case
₹648.6
MoS -48.5%
Ratio Trends
INDIAGLYCO · last 8 annual periods
ROE
10.2%
ROCE
13.2%
Operating Margin
—
Debt / Equity
0.84×
PE
103.4×
EV / EBITDA
13.5×
Historical Financials
INDIAGLYCO · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹5427 Cr | ₹6601 Cr | ₹1616 Cr | ₹2039 Cr | ₹3768 Cr | -8.7% |
| EBITDA | — | ₹507 Cr | ₹344 Cr | ₹429 Cr | ₹546 Cr | +1.9% |
| EBIT | ₹203 Cr | ₹418 Cr | ₹70.8 Cr | ₹83.2 Cr | — | -20.0% |
| PAT | ₹132 Cr | ₹340 Cr | ₹39.8 Cr | ₹42.2 Cr | ₹231 Cr | +15.1% |
| EPS (diluted) | ₹35.27 | ₹106.45 | ₹12.87 | ₹13.63 | — | -21.2% |
| CFO | ₹81.3 Cr | ₹91.4 Cr | ₹326 Cr | ₹439 Cr | ₹362 Cr | +45.3% |
| CapEx | — | — | — | — | ₹-760 Cr | — |
| FCF | — | — | — | — | ₹-398 Cr | — |
| Total Assets | — | ₹4631 Cr | ₹4858 Cr | ₹5617 Cr | ₹6176 Cr | +7.5% |
| Total Debt | — | — | ₹543 Cr | ₹596 Cr | ₹1892 Cr | +36.6% |
| Shareholders' Equity | — | — | ₹1901 Cr | ₹2051 Cr | ₹2256 Cr | +4.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
INDIAGLYCO vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| GNFC GNFC | — | — | Pending | 7.0% | — |
| ACI ARCHEAN CHEMICAL IND LTD | -51.9% | 33 | Data Limited | 8.7% | — |
| GUJALKALI GUJALKALI | — | — | Pending | -1.1% | — |
| EPIGRAL EPIGRAL LIMITED | +33.1% | 68 | Undervalued | 18.8% | — |
| DEEPAKFERT DEEPAKFERT | — | — | Pending | 14.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for INDIAGLYCO in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of INDIAGLYCO →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for INDIAGLYCO →
Compare
Head-to-head with peers
Compare INDIAGLYCO side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse INDIAGLYCONow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.